Supplementary tables: Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement

<p dir="ltr"><b>These are peer-reviewed supplementary materials for the article '</b><b>Costs and outcomes of mobile cardiac </b><b>outpatient telemetry monitoring </b><b>post-transcatheter aortic valve </b><b>replacement</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b></p><ul><li><b>Supplementary Table 1: </b>CPT and ICD-10 Codes</li><li><b>Supplementary Table 2:</b> Propensity score adjusted revenue center costs for patients with MCOT monitoring versus non-MCOT monitoring post-TAVR procedure</li></ul><p dir="ltr"><b>Aim:</b> To estimate the costs and outcomes of transcatheter aortic valve replacement (TAVR) recipients based on the use of mobile cardiac outpatient telemetry (MCOT) monitoring. <b>Materials & methods:</b> A retrospective database study was conducted to estimate costs, contribution margins (CMs), pacemaker insertions and other outcomes for patients undergoing TAVR procedures with MCOT monitoring postprocedure versus non-MCOT monitoring. <b>Results:</b> A total of 4164 patients were identified (283 MCOT monitoring and 3881 non-MCOT monitoring). The rate of pacemaker insertion following hospital discharge was higher in the MCOT cohort (6.6 MCOT vs 2.1% non-MCOT; p = 0.007). MCOT use was associated with lower costs and improved CMs of the index TAVR admission (costs: US$40,569 MCOT vs $43,289 non-MCOT; p = 0.003; CMs: US$7087 MCOT vs $5177 non-MCOT; p = 0.047) with no difference through the subsequent 60-day period following discharge. <b>Conclusion:</b> MCOT for ambulatory cardiac monitoring post-TAVR discharge is associated with higher rates of pacemaker insertion, at no overall greater costs.</p>